enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO)

49 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q4 2024.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,263,270 shares of 20,250,000 outstanding shares and own 21% of the company stock.
Largest 10 shareholders include KINGDON CAPITAL MANAGEMENT, L.L.C. (859,261 shares), Nantahala Capital Management, LLC (596,917 shares), VANGUARD GROUP INC (589,141 shares), Altium Capital Management LLC (310,000 shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (296,031 shares), JPMORGAN CHASE & CO (270,041 shares), Alyeska Investment Group, L.P. (209,180 shares), Westside Investment Management, Inc. (205,025 shares), GEODE CAPITAL MANAGEMENT, LLC (181,737 shares), and MORGAN STANLEY (126,932 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.